8
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      The pharmacokinetic and pharmacodynamic interactions between buprenorphine/naloxone and elvitegravir/cobicistat in subjects receiving chronic buprenorphine/naloxone treatment.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Interactions between HIV and opioid-dependence therapies are known to occur. We sought to determine if such interactions occurred between buprenorphine/naloxone and elvitegravir boosted with cobicistat.

          Related collections

          Author and article information

          Journal
          J. Acquir. Immune Defic. Syndr.
          Journal of acquired immune deficiency syndromes (1999)
          Ovid Technologies (Wolters Kluwer Health)
          1944-7884
          1525-4135
          Aug 01 2013
          : 63
          : 4
          Affiliations
          [1 ] Yale University AIDS Program, New Haven, CT 06510, USA. Robert.bruce@yale.edu
          Article
          10.1097/QAI.0b013e3182961d31
          23599011

          Comments

          Comment on this article